Evidence map›Paper›PMID 41504195›Full record

ArticleRevista de neurologia2025

Treatment Options for Patients With Moyamoya Disease: A Retrospective Cohort Study.

Yuting Luo, Chutong Guo, Shaoqing Wu, Xunsha Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Revista de neurologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuting LuoDepartment of Neurology, The First Affiliated Hospital, Sun Yat-sen University, 510080 Guangzhou, Guangdong, China.
Chutong GuoDepartment of Neurology, The First Affiliated Hospital, Sun Yat-sen University, 510080 Guangzhou, Guangdong, China.
Shaoqing WuGuangzhou Women and Children's Medical Center, Guangzhou Medical University, 510623 Guangzhou, Guangdong, China.
Xunsha SunDepartment of Neurology, The First Affiliated Hospital, Sun Yat-sen University, 510080 Guangzhou, Guangdong, China.

Funding

Guangdong Province International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases 2020A0505020004Guangdong Provincial Clinical Research Center for Neurological Diseases 2020B1111170002Guangdong Provincial Engineering Center for Major Neurological Disease TreatmentGuangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological DiseaseGuangzhou Clinical Research and Translational Center for Major Neurological DiseasesGuangzhou Major Difficult and Rare Diseases Project 2024MDRD02Kelin New Talent Program R08016National Natural Science Foundation of China 82071292National Natural Science Foundation of China 82271333Science and Technology Projects in Guangzhou 202201020652
6 · The paper itself

Abstract

purposeSurgical revascularization is the preferred treatment for most patients with Moyamoya disease (MMD). Nevertheless, a considerable number of eligible patients choose non-surgical management. This study aimed to identify factors influencing treatment decisions, with particular emphasis on asymptomatic MMD patients. MATERIALS AND

methodsWe conducted a retrospective analysis of MMD patients without surgical contraindications treated at our center between 2010 and 2022. Baseline characteristics were compared using Wilcoxon rank-sum and chi-squared tests. Multivariable logistic regression was used to identify factors associated with treatment selection.

resultsAmong the 147 included patients, 62.6% underwent surgical treatment. Younger age (OR = 0.88, 95% CI: 0.88-0.94,

conclusionYounger age is strongly associated with the choice of surgical treatment in MMD, including in asymptomatic cases.

Indexed as

Moyamoya DiseaseAdultAge FactorsCerebral RevascularizationCohort StudiesFemaleHumansMaleMiddle AgedRetrospective StudieshumanMoyamoya diseasesurgery

Identifiers

PMID41504195
PMCPMC12781205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.